Kappa free light chains could predict early disease course in multiple sclerosis.

Area of Science:

• Neurology
• Immunology
• Biochemistry

Background:

• Oligoclonal bands (OB) are established markers for multiple sclerosis (MS) prognosis.
• The prognostic value of cerebrospinal fluid (CSF) kappa free light chains (KFLC) for early MS progression remains underexplored.

Purpose of the Study:

• To investigate the predictive capability of KFLC for early disability in a cohort of Italian MS patients.
• To assess the relationship between KFLC levels and disease severity markers.

Main Methods:

• CSF KFLC and albumin levels were measured in 100 MS patients during diagnostic work-up.
• The K index (CSF/serum KFLC ratio to albumin) was calculated and correlated with clinical features, early treatment, and MS Severity Score (MSSS).

Main Results:

• The K index was a significant predictor of long-term disability, with higher values correlating with greater MSSS.
• Elevated K index was observed in patients receiving early treatment, suggesting its role in identifying those with more aggressive disease.
• Age at onset also predicted MS disability, but K index was not associated with other known prognostic factors like gender or MRI lesion load.

Conclusions:

• CSF KFLC, quantified by the K index, shows promise as a marker for predicting early disability in MS.
• While not a replacement for OB, KFLC offers a quantitative approach to assessing MS prognosis and guiding treatment decisions.